CXCR5 and COVID-19: Thus, B cell responses—most often characterized by elevated PBs, decreases in memory B cell subsets, enrichment in a T-bet+ B cell subset, and loss of CXCR5 expression—were evident in many hospitalized COVID-19 patients.